More than 3.8 million U.S. lung cancer deaths were averted during 1970 to 2022, and more than 76 million person-years of life ...

LiveLung, a nonprofit organization dedicated to supporting lung cancer patients, survivors and their care partners, will present a program Wednesday on the importance of lung cancer screening and ...

Researchers conducted a prospective, longitudinal cohort study involving individuals with current or former habit, who had ...

Lower odds of screening seen in association with lack of health insurance, being rural resident, not having a clinician ...

Due to the destructive nature of COPD on patients’ lungs and well-being, timely diagnosis is key, and integrating spirometry ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

IU Health created a mobile health care resource offering low-dose CT scans. The mobile unit is in Sellersburg this week as ...

By 2023, approximately 1 in 5 patients with non-small cell lung cancer or metastatic colorectal cancer were treated with a bevacizumab biosimilar.

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...

Johnson & Johnson has pulled ahead of rival AstraZeneca Plc in a race to dominate the blockbuster market for lung cancer ...

Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy ...